N,N-bis(2-hydroxybenzyl)ethylenediamine-N,N-diacetic acid in iron chelating therapy

摘要

The use of a novel mono-cationic salt of N,N-bis(2-hydroxybenzyl) ethylenediamine-N,N-diacetic acid (HBED) in iron chelating therapy is disclosed. In particular, the invention relates to the subcutaneous use of a mono cationic salt of HBED for treating a human with a disease treatable by an iron chelator such as iron overload, especially transfusional iron overload.